In connection with the clinical evaluation of dibutyryl cyclic AMP (D-CAMP) as a cardiotonic and diuretic agent, the metabolic effects of D-cAMP were studied in dogs with special reference to a possibility of lactic acidosis.
Eight fasting mongrel dogs were anesthetized with ethyl carbamate and chloralose. The animals were intubated and respiration was controlled with room air using a volume limited respirator (AIKA R-50). A content of end-tidal CO. was maintained at ap.
proximately 5%. D-cAMP was administered intravenously at a dose of 30 mg/kg. Arterial concentrations of glucose, lactate, pyruvate and non-esterified fatty acids (NEFA) were measured before, and 20, 40, 60 and 90 min after the administration of D-CAMP. Excess lactate and a ratio of lactate to pyruvate (L/P) were calculated from the values obtained.
The results are summarized in Table 1 . After the administration of D-cAMP, the blood glucose level was increased markedly with a maximum value at 20 min. It approached near the control at 90 min. The levels of lactate and pyruvate were also increased significantly after D-CAMP, with a maximum value at 60 min. Since an increase in lactate was almost the same extent as that in pyruvate, excess lactate and L/P did not change significantly throughout the experiments.
On the other hand, the level of NEFA was lowered significantly after D-CAMP.
The results of the present study suggested that D-cAMP caused an acceleration of glycogenolysis and a reduction of lipolysis. Excess lactate and L/P remained almost unchanged.
Therefore, NAD+/NADH or a radox potential seemed not to be affected by D-cAMP. However, under tissue hypoxia associated with shock or microcirculatory disturbance, D-CAMP may cause a further increase in lactic acid, resulting consequently in lactic acidosis. An inhibition of lactate reuptake due to liver function disturbance is also assumed to aggravate lactic acidosis. Although it has been postulated that an activation K. Takahashi and H. Kokubun 
